Is ZRVT or JNJ a better dividend investment in 2026?

ZRVT currently yields 1000000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: ZRVT offers higher current income.

What is the dividend yield difference between ZRVT and JNJ?

ZRVT has a forward dividend yield of 1000000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 999997.87 percentage points.

Home › Compare › ZRVT vs JNJ

ZRVT vs JNJ: Dividend Comparison 2026

ZRVT yields 1000000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZRVT wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZRVT

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full ZRVT calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — ZRVT vs JNJ

📍 ZRVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZRVT	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZRVT + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZRVT pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZRVT

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, ZRVT beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZRVT + JNJ for your $10,000?

ZRVT: 50%JNJ: 50%

100% JNJ50/50100% ZRVT

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZRVT

No analyst data

Altman Z

-7.5

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZRVT buys

JNJ buys

No recent congressional trades found for ZRVT or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZRVTJNJ

Forward yield	1000000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$30.3K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$4.7683311610149396e+36M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ZRVT vs JNJ ($10,000, DRIP)

Year	ZRVT Portfolio	ZRVT Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$10,592	$272.30	+$100.00M → ZRVT
2	$934,786,450,701	$934,679,439,252.34	$11,289	$357.73	+$934786.44M → ZRVT
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$12,123	$472.89	+$8165787108.57M → ZRVT
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$13,141	$629.86	+$66665884190957.63M → ZRVT
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$14,408	$846.81	+$508662171058048128.00M → ZRVT
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$16,021	$1,151.60	+$3.62723524842849e+21M → ZRVT
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$18,122	$1,588.22	+$2.417368115915061e+25M → ZRVT
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$20,930	$2,228.20	+$1.5056740286145463e+29M → ZRVT
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$8.764771002818475e+32M → ZRVT
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$4.7683925249533696e+36M → ZRVT

ZRVT vs JNJ: Complete Analysis 2026

ZRVT — Stock

Zurvita Holdings, Inc. markets health and wellness products in the United States, Hong Kong, Canada, Singapore, Australia, the United Kingdom, and the Dominican Republic. Its principal products comprise Zeal Wellness, an antioxidants and vitamins nutritional product in wild berry and bold grape flavors; Zeal Advanced Formula Protein Shakes, a source of dietary fiber in chocolate delight and vanilla crème flavors; Zeal cleanse, a herbal and probiotic cleanse; and Zeal burn, a thermogenic fat burner. The company sells its products through its network of independent sales consultants. Zurvita Holdings, Inc. is headquartered in Houston, Texas. Zurvita Holdings, Inc. is a subsidiary of The Amacore Group, Inc.

Full ZRVT Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ZRVT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZRVT vs SCHD ZRVT vs JEPI ZRVT vs O ZRVT vs KO ZRVT vs MAIN ZRVT vs ABBV ZRVT vs MRK ZRVT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.